Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
sE-selectin may mark endothelial effects of glycemic improvement; hypothesis-generating and requires prospective validation before clinical use.
We conclude that improvement in glycemic control by administration of insulin alone or insulin combined with either glibenclamide, metformin, or both agents induces a sustained decrease in sE-selectin, the magnitude of which seems to be dependent on the degree of improvement in glycemia. These data suggest that sE-selectin might provide a marker of effects of treatment of chronic hyperglycemia on endothelial activation.
No takes yet. Share an insight, caveat, or question.
Ryysy et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: